Mandate

Vinge advises Fouriertransform in connection with investment in NovaCast Technologies

February 04, 2010

Vinge has advised Fouriertransform, the Swedish state-owned venture capital company for the automotive industry, in its acquisition of shares through a directed new share issue in NovaCast Technologies AB (publ). NovaCast Technologies, which is listed on Nasdaq OMX Stockholm (Small Cap), develops and markets products and software intended to improve the efficiency and speed of production processes to automotive industry companies and their sub-contractors.

The investment amounts to SEK 40 million and, if approved, will make Fouriertransform the largest individual shareholder. The issue is conditional upon approval by an extraordinary shareholders’ meeting.

Vinge’s team consisted of partner Göran Nyström and associates David Andersson and Caroline Strömbäck.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026